Advances in the Treatment of Triple-Positive Breast Cancer

Xiaoyi Zeng, Xiaowei Huang, Zhi-De ZengProceedings of Anticancer Research 2025 · DOI

Abstract

Triple-positive breast cancer is a special type of breast cancer characterized by significant specificity in its clinical features and biological manifestations. Unlike the treatment strategies for simple hormone receptor (HR)-positive or human epidermal growth factor receptor 2 (HER2)-positive breast cancer, triple-positive breast cancer is sensitive to endocrine therapy, adjuvant therapy, and targeted therapy. With the in-depth study of the complex drug resistance mechanisms of triple-positive breast cancer, relevant treatment options are continuously optimized, providing new directions for the treatment of this disease.
BibTeX
@inproceedings{zeng2025advances,
  author = {Xiaoyi Zeng and Xiaowei Huang and Zhi-De Zeng},
  title = {{Advances in the Treatment of Triple-Positive Breast Cancer}},
  booktitle = {Proceedings of Anticancer Research},
  year = {2025},
  doi = {10.26689/par.v8i6.9750},
}

Loading related content...

Figure